OTC: RHHBY - Roche Holding

Yield per half year: +8.07%
Dividend yield: 0.00%
Sector: Healthcare

Roche Holding

48.0048.0044.0044.0040.0040.0036.0036.0032.0032.0028.0028.00Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
2.11 31.32 -93.26% 2.44 -13.53%
P/S 0.4014 3.24 -87.62%
P/BV 0.7293 3.11 -76.56%
P/FCF 20.45 16.56 23.44%
Ev/Ebitda 2.49 10.17 -75.56%
Ev/S 0.7957 1.93 -58.74%
Ev/FCF 4.2 14 -70%
E/P 0.0491 1.47 -96.66%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
9/10
34.51 25.1 37.53% 35.56 -2.94%
ROE 39.22 13.38 193.2%
ROA 12.71 6.25 103.28%
ROIC 26.27 15.56 68.84%
ROS 19.02 12.85 48.03%
ROCE 0 15.02 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
8/10
1.4 6.28 -77.69% 1.32 +5.68%
Nеt Debt/Ebitda 1.14 -5.74 -119.92%
Debt/Ratio 0.3229 0.2174 48.52%
Debt/Equity 1.21 12.43 -90.29%
Debt/Net Income 2.54 15.13 -83.22%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.56 -100% 3.44 -100%
Number of years of dividend growth 4 1.3 208.7%
DSI 0.8571 0.7874 8.86%
Average dividend growth 3.72 -247.19 -101.51%
Average percentage for 5 years 3.44 2.81 22.74%
Average percentage for payments 52.45 245.62 -78.64%
Difference from average difference in sector -1.56

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-1.67 60.04 -102.78%
Growth impulse Ebitda in 5 years 12.9 43.37 -70.26%
Growth impulse Net Income in 5 years -14.81 49.78 -129.75%
Growth impulse FCF in 5 years -34.55 29.75 -216.13%
Growth impulse EPS in 5 years -51.26 116.39 -144.04%
IP Score
5.81/10

Similar companies

Sino Biopharmaceutical Limited

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co., Ltd.

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription